Feasibility trial of Darwin OncoTreat and OncoTarget precision medicine testing to improve outcomes for patients with limited metastatic disease that failed first-line systemic therapy - Rachel Radigan; Ashish Sangal; Dong Zhang; Jonathan Weber; Megha Schmalzle; Alexa Finkelstein; Vaibhav Duggal; Johnny Kao (PLoS ONE, 2025)